HopeStage
Back to all studies
CompletedNCT02029989

Point-of-Care Metabolic Health Checks for People Taking Antipsychotic Medication

About this titleRead the official source — NCT02029989
Device studyAges 18–64United StatesBipolarity
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 64 years.

Listed locations
DuluthSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2010
Recruitment status
Completed
Enrollment listed in the registry
121
Sponsor
University of Minnesota
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Device
Locations
United States
Age range
From 18 Years to 64 Years
Official registry ID
NCT02029989
Official title
Show the full official title

Can Point-of-care Testing (POCT) and Assistance From Comprehensive Medication Management (CMM) Pharmacists Improve Early Detection and Management of Metabolic Syndrome in Patients Treated With Antipsychotic Medications?

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Duluth

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Minnesota, a university.

Who was this study for?

Listed age limits: 18 years to 64 years.

Want to explore more studies?

Explore studies